http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108265024-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-44 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0686 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02 |
| filingDate | 2018-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108265024-B |
| titleOfInvention | Serum-free medium suitable for MDCK cell full-suspension culture and preparation method thereof |
| abstract | The invention relates to the technical field of cell culture, in particular to a serum-free medium suitable for full suspension culture of MDCK cells and a preparation method thereof. The culture medium comprises various amino acids, vitamins, salts, lipids, trace elements, buffering agents, hormones and the like; the serum-free medium can be prepared by conventional preparation method. The culture medium provided by the invention is used for full suspension culture of MDCK, does not generate side effects accompanied with protein components, has good safety, small difference of different batches, low cost, favorable separation of downstream products of cells and good safety, and is suitable for producing biological products such as vaccines and the like. The culture medium can not only reduce the aggregation phenomenon of the cells during culture, but also further increase the hypoxia tolerance of the cells and increase the cell survival rate. |
| priorityDate | 2018-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 258.